Molecular Genealogy of Metabolic-associated Hepatocellular Carcinoma
Seminars in Liver Disease · 2024-05 · 44 (02) · 147-158
DOI: 10.1055/a-2289-2298 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Liver Disease, online erschienen am 18.04.2024. Verfasst von Takahiro Kodama und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Tumor Microenvironment, Genetic Predisposition to Disease. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
This review examines the latest epidemiological and molecular pathogenic findings of metabolic-associated hepatocellular carcinoma (HCC). Its increasing prevalence is a significant concern and reflects the growing burden of obesity and metabolic diseases, including metabolic dysfunction-associated steatotic liver disease, formerly known as nonalcoholic fatty liver disease, and type 2 diabetes. Metabolic-associated HCC has unique molecular abnormality and distinctive gene expression patterns implicating aberrations in bile acid, fatty acid metabolism, oxidative stress, and proinflammatory pathways. Furthermore, a notable frequency of single nucleotide polymorphisms in genes such as patatin-like phospholipase domain-containing 3, transmembrane 6 superfamily member 2, glucokinase regulator, and membrane-bound O-acyltransferase domain-containing 7 has been observed. The tumor immune microenvironment of metabolic-associated HCC is characterized by unique phenotypes of macrophages, neutrophils, and T lymphocytes. Additionally, the pathogenesis of metabolic-associated HCC is influenced by abnormal lipid metabolism, insulin resistance, and dysbiosis. In conclusion, deciphering the intricate interactions among metabolic processes, genetic predispositions, inflammatory responses, immune regulation, and microbial ecology is imperative for the development of novel therapeutic and preventative measures against metabolic-associated HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Kodama, T., & Takehara, T. (2024). Molecular Genealogy of Metabolic-associated Hepatocellular Carcinoma. Seminars in Liver Disease, 44(02), 147-158. https://doi.org/10.1055/a-2289-2298
Vancouver
Kodama T, Takehara T. Molecular Genealogy of Metabolic-associated Hepatocellular Carcinoma. Seminars in Liver Disease. 2024;44(02):147-158. doi:10.1055/a-2289-2298
BibTeX
@article{Kodama2024,
author = {Kodama, Takahiro and Takehara, Tetsuo},
title = {Molecular Genealogy of Metabolic-associated Hepatocellular Carcinoma},
journal = {Seminars in Liver Disease},
year = {2024},
volume = {44},
number = {02},
pages = {147--158},
doi = {10.1055/a-2289-2298}
}
EUVIMED